Clinical Trial Update: Post Market Clinical Follow-up Study for the Pamira ICD Lead Family [NA]

View source ↗

Summary

Post-market clinical follow-up study of the Pamira ICD Lead Family by Biotronik has completed, evaluating long-term safety and performance in patients with hear…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Tachyarrhythmia

Drugs mentioned

• Pamira ICD Lead Family

Snippet

Sponsor: Biotronik SE & Co. KG | Conditions: Heart Failure, Tachyarrhythmia | NA | Status: COMPLETED